 Keith Millikan
Concepts (257)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hernia, Ventral | 9 | 2018 | 24 | 2.290 |
Why?
| | Surgical Mesh | 11 | 2014 | 30 | 2.070 |
Why?
| | Herniorrhaphy | 9 | 2018 | 35 | 1.940 |
Why?
| | Hernia, Inguinal | 7 | 2016 | 22 | 1.600 |
Why?
| | Postoperative Complications | 20 | 2018 | 983 | 1.470 |
Why?
| | Obesity, Morbid | 2 | 2017 | 70 | 1.380 |
Why?
| | Laparoscopy | 13 | 2016 | 174 | 1.250 |
Why?
| | Adenocarcinoma | 6 | 2016 | 228 | 1.220 |
Why?
| | Esophageal Neoplasms | 7 | 2002 | 59 | 1.140 |
Why?
| | Stomach Neoplasms | 3 | 2016 | 38 | 0.930 |
Why?
| | General Surgery | 4 | 2015 | 56 | 0.810 |
Why?
| | Cholecystectomy, Laparoscopic | 7 | 2015 | 36 | 0.740 |
Why?
| | Gastroplasty | 1 | 2016 | 27 | 0.710 |
Why?
| | Clinical Clerkship | 3 | 2013 | 27 | 0.690 |
Why?
| | Gastric Bypass | 1 | 2016 | 52 | 0.670 |
Why?
| | Middle Aged | 42 | 2018 | 10247 | 0.670 |
Why?
| | Aged | 31 | 2018 | 9058 | 0.650 |
Why?
| | Carcinoma | 3 | 2016 | 80 | 0.640 |
Why?
| | Treatment Outcome | 22 | 2018 | 3397 | 0.610 |
Why?
| | Male | 44 | 2018 | 15795 | 0.600 |
Why?
| | Digestive System Surgical Procedures | 2 | 2003 | 22 | 0.590 |
Why?
| | Educational Measurement | 3 | 2015 | 63 | 0.580 |
Why?
| | Humans | 59 | 2018 | 27077 | 0.580 |
Why?
| | Recurrence | 10 | 2017 | 350 | 0.570 |
Why?
| | Retrospective Studies | 25 | 2018 | 2843 | 0.570 |
Why?
| | Quality Improvement | 4 | 2014 | 148 | 0.550 |
Why?
| | Adult | 30 | 2018 | 8863 | 0.540 |
Why?
| | Hepatectomy | 6 | 2015 | 59 | 0.530 |
Why?
| | Colonic Neoplasms | 3 | 2016 | 82 | 0.530 |
Why?
| | Female | 42 | 2018 | 16186 | 0.520 |
Why?
| | Esophagectomy | 5 | 2002 | 23 | 0.510 |
Why?
| | Liver Neoplasms | 5 | 2000 | 118 | 0.510 |
Why?
| | Colectomy | 3 | 2016 | 33 | 0.500 |
Why?
| | Curriculum | 2 | 2003 | 133 | 0.490 |
Why?
| | Polytetrafluoroethylene | 2 | 2003 | 8 | 0.490 |
Why?
| | Pancreatic Neoplasms | 5 | 2013 | 158 | 0.430 |
Why?
| | Students, Medical | 2 | 2013 | 41 | 0.400 |
Why?
| | Aged, 80 and over | 13 | 2017 | 4622 | 0.380 |
Why?
| | Ambulatory Surgical Procedures | 3 | 2007 | 75 | 0.360 |
Why?
| | Risk Factors | 9 | 2018 | 2333 | 0.360 |
Why?
| | Prospective Studies | 9 | 2014 | 1609 | 0.350 |
Why?
| | Survival Rate | 9 | 2015 | 425 | 0.340 |
Why?
| | Smoking | 2 | 2016 | 173 | 0.330 |
Why?
| | Hernia, Hiatal | 2 | 2014 | 14 | 0.310 |
Why?
| | Polypropylenes | 1 | 2003 | 2 | 0.290 |
Why?
| | Gastrectomy | 3 | 2015 | 22 | 0.290 |
Why?
| | Cholangiography | 4 | 2015 | 12 | 0.270 |
Why?
| | Pancreaticoduodenectomy | 3 | 2013 | 36 | 0.270 |
Why?
| | Follow-Up Studies | 7 | 2017 | 1887 | 0.270 |
Why?
| | Prognosis | 6 | 2017 | 935 | 0.270 |
Why?
| | Colorectal Neoplasms | 4 | 1997 | 107 | 0.260 |
Why?
| | Hernia, Femoral | 1 | 2001 | 1 | 0.250 |
Why?
| | Transforming Growth Factor alpha | 1 | 2000 | 7 | 0.240 |
Why?
| | Lymphokines | 1 | 2000 | 13 | 0.240 |
Why?
| | Endothelial Growth Factors | 1 | 2000 | 8 | 0.240 |
Why?
| | Peritoneum | 2 | 2003 | 16 | 0.230 |
Why?
| | Elective Surgical Procedures | 2 | 2017 | 48 | 0.230 |
Why?
| | United States | 9 | 2016 | 2140 | 0.230 |
Why?
| | Neovascularization, Pathologic | 1 | 2000 | 65 | 0.230 |
Why?
| | Suture Techniques | 3 | 2007 | 128 | 0.220 |
Why?
| | Adolescent | 6 | 2007 | 2394 | 0.210 |
Why?
| | Pneumonia | 2 | 2016 | 76 | 0.210 |
Why?
| | Carcinoma, Squamous Cell | 2 | 1997 | 188 | 0.210 |
Why?
| | Intra-Abdominal Hypertension | 1 | 2018 | 2 | 0.210 |
Why?
| | Compartment Syndromes | 1 | 2018 | 10 | 0.210 |
Why?
| | Cholelithiasis | 1 | 1998 | 10 | 0.210 |
Why?
| | Gallstones | 1 | 1998 | 11 | 0.210 |
Why?
| | Cholecystectomy | 3 | 2013 | 16 | 0.210 |
Why?
| | Internship and Residency | 3 | 2015 | 155 | 0.200 |
Why?
| | Surgical Wound Infection | 3 | 2016 | 99 | 0.200 |
Why?
| | Lipoma | 1 | 2017 | 7 | 0.200 |
Why?
| | Myoepithelioma | 1 | 2017 | 4 | 0.200 |
Why?
| | Trachea | 1 | 1997 | 18 | 0.200 |
Why?
| | Survival Analysis | 6 | 2015 | 377 | 0.190 |
Why?
| | Soft Tissue Neoplasms | 1 | 2017 | 33 | 0.190 |
Why?
| | Liver | 2 | 1997 | 204 | 0.190 |
Why?
| | Databases, Factual | 5 | 2016 | 323 | 0.190 |
Why?
| | Mesenteric Vascular Occlusion | 1 | 1996 | 4 | 0.190 |
Why?
| | Analysis of Variance | 3 | 2003 | 364 | 0.180 |
Why?
| | Cytoreduction Surgical Procedures | 1 | 2016 | 7 | 0.180 |
Why?
| | Enterostomy | 1 | 2016 | 6 | 0.180 |
Why?
| | Portal Vein | 1 | 1996 | 44 | 0.170 |
Why?
| | Prostheses and Implants | 1 | 1997 | 165 | 0.170 |
Why?
| | Radiation Tolerance | 1 | 1995 | 8 | 0.170 |
Why?
| | Thrombosis | 1 | 1996 | 63 | 0.170 |
Why?
| | Fundoplication | 2 | 2013 | 24 | 0.170 |
Why?
| | Retroperitoneal Neoplasms | 1 | 2015 | 8 | 0.170 |
Why?
| | Organs at Risk | 1 | 2015 | 16 | 0.170 |
Why?
| | Tumor Burden | 1 | 2015 | 42 | 0.170 |
Why?
| | Liver Regeneration | 1 | 1995 | 24 | 0.170 |
Why?
| | Radiation Oncology | 1 | 2015 | 17 | 0.170 |
Why?
| | Gallbladder Neoplasms | 1 | 2015 | 7 | 0.170 |
Why?
| | Certification | 1 | 2015 | 54 | 0.170 |
Why?
| | Esophagus | 2 | 2012 | 59 | 0.160 |
Why?
| | Appendectomy | 1 | 2014 | 10 | 0.160 |
Why?
| | Hospital Costs | 1 | 1996 | 69 | 0.160 |
Why?
| | Appendicitis | 1 | 2014 | 10 | 0.160 |
Why?
| | Abdominal Neoplasms | 1 | 2014 | 13 | 0.160 |
Why?
| | Ovarian Neoplasms | 1 | 2016 | 75 | 0.160 |
Why?
| | Body Mass Index | 1 | 2017 | 391 | 0.160 |
Why?
| | Safety | 2 | 2007 | 56 | 0.160 |
Why?
| | Image-Guided Biopsy | 1 | 2014 | 29 | 0.160 |
Why?
| | Neoplasm Staging | 5 | 2015 | 483 | 0.160 |
Why?
| | Radiotherapy Planning, Computer-Assisted | 1 | 2015 | 73 | 0.160 |
Why?
| | Logistic Models | 4 | 2016 | 459 | 0.160 |
Why?
| | Lymphoma | 1 | 2014 | 55 | 0.160 |
Why?
| | Clinical Competence | 3 | 2013 | 251 | 0.160 |
Why?
| | Pain, Postoperative | 3 | 2013 | 244 | 0.150 |
Why?
| | Biliary Dyskinesia | 1 | 2013 | 4 | 0.150 |
Why?
| | Cholestasis | 1 | 1993 | 8 | 0.150 |
Why?
| | Multivariate Analysis | 3 | 2016 | 371 | 0.150 |
Why?
| | Intestine, Small | 1 | 2014 | 35 | 0.150 |
Why?
| | Specialties, Surgical | 1 | 2013 | 5 | 0.150 |
Why?
| | Surgical Procedures, Operative | 1 | 2013 | 34 | 0.150 |
Why?
| | Gallbladder Diseases | 1 | 2013 | 6 | 0.150 |
Why?
| | Duodenal Neoplasms | 1 | 2013 | 10 | 0.150 |
Why?
| | Education, Medical, Undergraduate | 1 | 2013 | 30 | 0.150 |
Why?
| | Abdominal Wall | 1 | 2013 | 4 | 0.140 |
Why?
| | Sarcoma | 1 | 2015 | 93 | 0.140 |
Why?
| | Length of Stay | 5 | 2014 | 325 | 0.140 |
Why?
| | Operative Time | 4 | 2014 | 85 | 0.140 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2013 | 39 | 0.140 |
Why?
| | Patient Satisfaction | 2 | 2013 | 264 | 0.140 |
Why?
| | Education, Medical, Graduate | 1 | 2013 | 68 | 0.140 |
Why?
| | Practice Guidelines as Topic | 1 | 2015 | 349 | 0.130 |
Why?
| | Severity of Illness Index | 1 | 2017 | 1144 | 0.130 |
Why?
| | Prosthesis Implantation | 2 | 2013 | 43 | 0.130 |
Why?
| | Sepsis | 1 | 2014 | 149 | 0.130 |
Why?
| | Stents | 1 | 1993 | 147 | 0.130 |
Why?
| | Esophageal Achalasia | 1 | 2012 | 22 | 0.130 |
Why?
| | Kidney | 1 | 2013 | 190 | 0.130 |
Why?
| | Morbidity | 3 | 2014 | 65 | 0.120 |
Why?
| | Time Factors | 4 | 2014 | 1761 | 0.120 |
Why?
| | Lymph Node Excision | 2 | 2015 | 38 | 0.120 |
Why?
| | Reoperation | 5 | 2016 | 808 | 0.110 |
Why?
| | Program Evaluation | 2 | 2013 | 146 | 0.100 |
Why?
| | Hernia, Abdominal | 1 | 2007 | 2 | 0.100 |
Why?
| | Polyurethanes | 1 | 2007 | 10 | 0.100 |
Why?
| | Omentum | 1 | 2007 | 9 | 0.100 |
Why?
| | Chicago | 2 | 2001 | 841 | 0.100 |
Why?
| | Statistics, Nonparametric | 2 | 2000 | 157 | 0.100 |
Why?
| | Child | 3 | 2001 | 1348 | 0.080 |
Why?
| | Age Factors | 2 | 2016 | 841 | 0.080 |
Why?
| | Sutures | 2 | 2003 | 41 | 0.080 |
Why?
| | Anastomosis, Surgical | 2 | 2016 | 55 | 0.080 |
Why?
| | Sensitivity and Specificity | 3 | 2007 | 583 | 0.080 |
Why?
| | Algorithms | 2 | 2015 | 389 | 0.080 |
Why?
| | Longitudinal Studies | 1 | 2007 | 1237 | 0.070 |
Why?
| | Tomography, X-Ray Computed | 4 | 2015 | 829 | 0.070 |
Why?
| | Comorbidity | 2 | 2016 | 497 | 0.070 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2014 | 266 | 0.070 |
Why?
| | Vascular Diseases | 1 | 2002 | 43 | 0.070 |
Why?
| | Disease-Free Survival | 2 | 2000 | 230 | 0.070 |
Why?
| | Probability | 1 | 2002 | 96 | 0.070 |
Why?
| | Confidence Intervals | 1 | 2002 | 104 | 0.070 |
Why?
| | Ultrasonography | 3 | 1997 | 187 | 0.060 |
Why?
| | Models, Educational | 1 | 2001 | 38 | 0.060 |
Why?
| | Workload | 1 | 2001 | 36 | 0.060 |
Why?
| | Vascular Endothelial Growth Factors | 1 | 2000 | 10 | 0.060 |
Why?
| | von Willebrand Factor | 1 | 2000 | 11 | 0.060 |
Why?
| | Intraoperative Care | 2 | 1998 | 56 | 0.060 |
Why?
| | Barrett Esophagus | 1 | 2000 | 19 | 0.060 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2000 | 59 | 0.060 |
Why?
| | Lymphatic Metastasis | 1 | 2000 | 99 | 0.060 |
Why?
| | Risk Assessment | 2 | 2017 | 727 | 0.060 |
Why?
| | Endosonography | 1 | 1999 | 14 | 0.060 |
Why?
| | Infant | 1 | 2001 | 598 | 0.060 |
Why?
| | Adenocarcinoma, Papillary | 1 | 1999 | 2 | 0.050 |
Why?
| | Child, Preschool | 1 | 2001 | 730 | 0.050 |
Why?
| | Neoplasm Recurrence, Local | 1 | 2000 | 182 | 0.050 |
Why?
| | Cholangiopancreatography, Endoscopic Retrograde | 1 | 1998 | 9 | 0.050 |
Why?
| | Liver Function Tests | 1 | 1998 | 29 | 0.050 |
Why?
| | Patient Selection | 1 | 2000 | 241 | 0.050 |
Why?
| | Bronchial Neoplasms | 1 | 1997 | 14 | 0.050 |
Why?
| | Groin | 1 | 2017 | 6 | 0.050 |
Why?
| | Thigh | 1 | 2017 | 34 | 0.050 |
Why?
| | Incidental Findings | 1 | 2017 | 18 | 0.050 |
Why?
| | Pilot Projects | 2 | 1997 | 394 | 0.050 |
Why?
| | Combined Modality Therapy | 2 | 1997 | 456 | 0.050 |
Why?
| | Neoplasm Invasiveness | 1 | 1997 | 100 | 0.050 |
Why?
| | Radiotherapy, Adjuvant | 1 | 2017 | 86 | 0.050 |
Why?
| | Cryosurgery | 1 | 1997 | 16 | 0.050 |
Why?
| | Diagnosis, Differential | 2 | 2014 | 447 | 0.050 |
Why?
| | Intestinal Polyps | 1 | 1996 | 1 | 0.050 |
Why?
| | Mesenteric Veins | 1 | 1996 | 1 | 0.050 |
Why?
| | Sigmoid Neoplasms | 1 | 1996 | 1 | 0.050 |
Why?
| | Biopsy, Needle | 1 | 2017 | 115 | 0.050 |
Why?
| | Angina Pectoris | 1 | 2016 | 18 | 0.050 |
Why?
| | Peripheral Vascular Diseases | 1 | 2016 | 13 | 0.050 |
Why?
| | Rectal Neoplasms | 1 | 1996 | 26 | 0.050 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 35 | 0.040 |
Why?
| | Predictive Value of Tests | 1 | 1998 | 592 | 0.040 |
Why?
| | Cost Savings | 1 | 1996 | 34 | 0.040 |
Why?
| | Immunohistochemistry | 1 | 2017 | 487 | 0.040 |
Why?
| | Liver Neoplasms, Experimental | 1 | 1995 | 1 | 0.040 |
Why?
| | Bilirubin | 1 | 1995 | 13 | 0.040 |
Why?
| | Cardia | 1 | 1995 | 3 | 0.040 |
Why?
| | Diabetes Mellitus | 1 | 2016 | 105 | 0.040 |
Why?
| | Aspartate Aminotransferases | 1 | 1995 | 19 | 0.040 |
Why?
| | Cost-Benefit Analysis | 1 | 1996 | 130 | 0.040 |
Why?
| | Alanine Transaminase | 1 | 1995 | 23 | 0.040 |
Why?
| | Intestines | 1 | 2016 | 99 | 0.040 |
Why?
| | Random Allocation | 1 | 1995 | 157 | 0.040 |
Why?
| | Neoplasm Metastasis | 1 | 1995 | 141 | 0.040 |
Why?
| | Observer Variation | 1 | 2015 | 131 | 0.040 |
Why?
| | Consensus | 1 | 2015 | 61 | 0.040 |
Why?
| | Ultrasonography, Interventional | 1 | 2015 | 64 | 0.040 |
Why?
| | Jejunum | 1 | 1994 | 14 | 0.040 |
Why?
| | Surgical Stapling | 1 | 1994 | 9 | 0.040 |
Why?
| | Hypertension | 1 | 2016 | 217 | 0.040 |
Why?
| | Sex Factors | 1 | 2016 | 483 | 0.040 |
Why?
| | Hospitals, University | 1 | 1994 | 45 | 0.040 |
Why?
| | Digestive System Neoplasms | 1 | 1993 | 6 | 0.040 |
Why?
| | Illinois | 1 | 2014 | 221 | 0.040 |
Why?
| | Attitude of Health Personnel | 1 | 2015 | 167 | 0.040 |
Why?
| | Radiography | 1 | 1996 | 702 | 0.040 |
Why?
| | Blood Transfusion | 1 | 2014 | 63 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 1 | 1995 | 476 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2015 | 148 | 0.040 |
Why?
| | Ileus | 1 | 2013 | 4 | 0.040 |
Why?
| | Seroma | 1 | 2013 | 4 | 0.040 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2013 | 17 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 1999 | 405 | 0.040 |
Why?
| | Wound Healing | 1 | 2014 | 164 | 0.040 |
Why?
| | Spinal Fusion | 1 | 1999 | 374 | 0.040 |
Why?
| | Rats | 1 | 1995 | 927 | 0.030 |
Why?
| | Device Removal | 1 | 2013 | 97 | 0.030 |
Why?
| | Intraoperative Period | 3 | 1997 | 39 | 0.030 |
Why?
| | Disease Models, Animal | 1 | 1995 | 761 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2013 | 625 | 0.030 |
Why?
| | Cohort Studies | 1 | 2015 | 1704 | 0.030 |
Why?
| | Quality of Life | 1 | 2013 | 529 | 0.030 |
Why?
| | Surgical Instruments | 1 | 2007 | 20 | 0.020 |
Why?
| | Ischemia | 1 | 2007 | 27 | 0.020 |
Why?
| | Blood Loss, Surgical | 2 | 1999 | 64 | 0.020 |
Why?
| | Laparotomy | 2 | 1997 | 21 | 0.020 |
Why?
| | Animals | 1 | 1995 | 4896 | 0.020 |
Why?
| | Prosthesis Design | 1 | 2007 | 449 | 0.020 |
Why?
| | Pancreatitis | 1 | 2002 | 27 | 0.020 |
Why?
| | Medical Records | 1 | 2002 | 39 | 0.020 |
Why?
| | Chronic Disease | 1 | 2002 | 485 | 0.010 |
Why?
| | Cystadenocarcinoma | 1 | 1999 | 1 | 0.010 |
Why?
| | Cystadenoma | 1 | 1999 | 1 | 0.010 |
Why?
| | Retroperitoneal Space | 1 | 1999 | 14 | 0.010 |
Why?
| | Orthopedic Fixation Devices | 1 | 1999 | 24 | 0.010 |
Why?
| | Fluorouracil | 1 | 1997 | 88 | 0.010 |
Why?
| | Radiotherapy Dosage | 1 | 1997 | 145 | 0.010 |
Why?
| | Cisplatin | 1 | 1997 | 106 | 0.010 |
Why?
| | Feasibility Studies | 1 | 1997 | 222 | 0.010 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 1994 | 7 | 0.010 |
Why?
| | Esophagogastric Junction | 1 | 1994 | 13 | 0.010 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 1997 | 381 | 0.010 |
Why?
| | Puerto Rico | 1 | 1993 | 15 | 0.010 |
Why?
| | Bile Ducts | 1 | 1993 | 10 | 0.010 |
Why?
| | Data Collection | 1 | 1993 | 117 | 0.010 |
Why?
| | Intraoperative Complications | 1 | 1993 | 72 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 1997 | 1128 | 0.010 |
Why?
|
|
Millikan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|